CClinicalTrials.gg
Status unknownNCT03290872Updated Sep 25, 2017

Mitral Annuloplasty Rings RCT

An interventional study of Carpentier Edwards Physio 2 Complete flexible mitral ring and Simplici T Partial flexible mitral annuloplasty ring in Degenerative Mitral Valve Disease, sponsored by University Health Network, Toronto. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-25.

Sponsored by University Health Network, Toronto · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Recently published work has suggested that mitral valve annuloplasty ring type may affect the development of post-repair mitral stenosis resulting in adverse intracardiac hemodynamics and poor functional status. However, these results have not been comprehensively determined in a systematic manner on a general mitral valve repair population. As well, an underlying mechanism for these findings is not understood.

The investigators hypothesize that mitral valve repair with a complete annuloplasty ring (Carpentier-Edwards Physio II) when compared to repair with a partial annuloplasty ring (Simplici- T) may not necessarily result in elevated mitral gradients consistent with functional mitral stenosis (FMS). Currently no prospective data exists to test the hypothesis that a correctly sized, flexible complete annuloplasty ring has detrimental effects.

As 60% of annuloplasty rings used in surgical repair of degenerative mitral valve disease in North America utilizes one of the many forms of complete flexible rings available, this information is urgently required.

The investigators will evaluate: 1) the effect on mitral valve hemodynamics, 2) changes to mitral annular, valvular and subvalvular structure and function with 3D echocardiography, and 3) the effect on patient functional capacity at 1 year.

If FMS early post repair is a real phenomenon, the investigators hope to better understand the mechanisms through the use of advanced imaging techniques-namely 3D modeling of the mitral valvular apparatus, aortic mitral interactions and LV remodeling.

02

Conditions studied

  • Degenerative Mitral Valve Disease
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Mitral regurgitation secondary to degenerative valve disease referred to Prof Tirone David (Co-investigator) will be invited to take part.
  • The mitral valve anatomy must be anatomy suitable for repair.
  • The patient must be able to perform treadmill exercise echocardiography.
  • The patient must be over 18 years of age.

Exclusion criteria

Exclusion Criteria:

  • Any presence of life-limiting disease process, for example advanced malignancy.
  • Hemodynamically unstable patients in cardiogenic shock
  • Concomitant aortic valve disease/surgery
  • Previous mitral valve repair
  • Impaired left ventricular systolic function as defined by a left ventricular ejection fraction of ≤ 50%.
  • If the patient lives out of state or cannot attend follow up visits.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Carpentier Edwards Physio 2 Complete flexible mitral ring

    Mitral Valve Annuloplasty Ring Repair using Carpentier Edwards Physio 2 Complete flexible mitral ring

    Device: Carpentier Edwards Physio 2 Complete flexible mitral ring

  • Active comparator
    Simplici T Partial flexible mitral annuloplasty ring

    Mitral Valve Annuloplasty Ring Repair using Simplici T Partial flexible mitral annuloplasty ring

    Device: Simplici T Partial flexible mitral annuloplasty ring

Interventions

  • DeviceCarpentier Edwards Physio 2 Complete flexible mitral ring

    Mitral valve Annuloplasty Ring repair using a Carpentier Edwards Physio 2 Complete flexible mitral ring

  • DeviceSimplici T Partial flexible mitral annuloplasty ring

    Mitral valve Annuloplasty Ring repair using a Simplici T Partial flexible mitral annuloplasty ring

05

What researchers measure

Primary outcomes

  1. Mean mitral valve gradient

    Mean mitral valve gradient measured by transthoracic echocardiogram

    Time frame: 1 year

Secondary outcomes

  1. Left ventricular remodelling

    Assessment of left ventricular remodelling obtained from transthoracic echocardiography performed pre-operatively and at 1 year post surgery using 3D LV end-diastolic volume and 3D end-systolic volume measurements and 3D LV ejection fraction

    Time frame: 1 year

  2. Aortic-mitral coupling

    3D transesophageal echocardiogram assessment intra-operatively both pre and post bypass assessing the entire mitral valvular and subvalvular apparatus, the left ventricle and the aortic valve to assess aortic-mitral valvular coupling and to determine whether there is a difference observed in aorto-mitral coupling between complete and partial ring repairs

    Time frame: 1 year

  3. Change in functional capacity

    Functional capacity will be specifically assessed using workload achieved on stress transthoracic echocardiogram studies performed pre surgery and at 1 year post surgery. Measurements acquired will include total exercise time and total workload achieved. Also patients will complete SF-36 questionnaires pre-surgery and at 1 year post surgery for further assessment of change in functional capacity

    Time frame: 1 year

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03290872
Lead sponsor
University Health Network, Toronto
Responsible party
Sponsor
First posted
Sep 25, 2017
Start date
Sep 2017 (estimated)
Primary completion
Sep 2019 (estimated)
Completion
Sep 2019 (estimated)
Last update
Sep 25, 2017

Study contacts

Wendy W Tsang, MD
Contact
Wendy.Tsang@uhn.ca
4163403155
Kate H Rankin, MBBS
Contact
kate.rankin@uhn.ca
4163403155
Wendy W Tsang, MD
principal investigator · University Health Network, Toronto General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion